Tuesday, September 7, 2021

A RANDOMIZED TRIAL - INTENSIVE TREATMENT BASED IN IVERMECTIN AND IOTA-CARRAGEENAN AS PRE-EXPOSURE PROPHYLAXIS FOR COVID- 19 IN HEALTHCARE AGENTS



The authors have declared no competing interest. This study was supported by internal funding. There is not a financial sponsor and there is not conflict of interest.

ORIGINAL LINK